APA (7th ed.) Citation

Harris, J. E., Papp, K., Ezzedine, K., Sebastian, M., Pandya, A. G., Seneschal, J., . . . Zdybski, J. (2026). Open-label treatment extension of ruxolitinib cream in vitiligo: Findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study. British Journal of Dermatology, 194(3), 591. https://doi.org/10.1093/bjd/ljaf485

Chicago Style (17th ed.) Citation

Harris, John E., et al. "Open-label Treatment Extension of Ruxolitinib Cream in Vitiligo: Findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) Long-term Extension Phase III Study." British Journal of Dermatology 194, no. 3 (2026): 591. https://doi.org/10.1093/bjd/ljaf485.

MLA (9th ed.) Citation

Harris, John E., et al. "Open-label Treatment Extension of Ruxolitinib Cream in Vitiligo: Findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) Long-term Extension Phase III Study." British Journal of Dermatology, vol. 194, no. 3, 2026, p. 591, https://doi.org/10.1093/bjd/ljaf485.